1、该刊只有国际刊号。

2、投稿方式：在线投稿。

3、官网网址（微信公众号信息）：

https://www.sciencedirect.com/journal/integrated-diagnostics

4、投稿系统：

https://www.editorialmanager.com/intdia/default2.aspx

5、联系邮箱：id_journal@zju.edu.cn

（微信公众号信息）

6、出刊日期：年刊，一年出版一期。

7、官方微信公众号：ID整合诊断

8、微信公众号信息：前期发表文章免出版费

2026年5月6日星期三

Integrated Diagnostics (ID) | 整合诊断期刊正式上线

【官方微信公众号信息】

ID整合诊断 2026年2月2日

期刊简介

办刊目标

多模态生物标志物、诊断大数据、新材料等整合诊断研究方向的全方位交流平台

Integrated diganostics是一本由浙江大学、浙江大学医学院附属邵逸夫医院和爱思唯尔、浙江大学出版社联合出版的开放获取学术出版物。

本期刊旨在推动临床诊断为中心的转化医学研究，加速诊断技术创新，交叉整合多学科前沿进展，革新医学诊断范式，加强新型临床诊断技术的标准化和临床转化评估。特色是整合的诊断方法及其临床应用。

本期刊主要关注跨学科领域的临床诊断转化研究和创新，包括但不限于

新型生物标志物、疾病机制与先进诊断平台

液体活检

精准药物监测

临床前诊断、诊断材料、生物信息学，以及人工智能驱动的计算方法

联接基础研究、技术与临床应用的综述和原创性研究，旨在加速诊断创新并提升患者结局

Aim and Scope

Translational research and clinical diagnostic innovation in interdisciplinary fields.

Novel biomarkers, disease mechanisms, advanced diagnostic platforms

Liquid biopsy

Precise drug monitoring

Preclinical diagnostics, diagnostic materials, bioinformatics, and AI-driven computational

Concise

reviews and original research that bridge basic science, technology,

and clinical application, aiming to accelerate diagnostic innovation and

improve patient outcomes.

期刊特色

本刊优势

跨学科交流平台：关注所有整合诊断相关的研究，文章接受范围广

赞助出版费：前期发表文章免出版费（Waived Publication Charges）

见刊速度快：送审到首次同行评审完成不超过30天（First reviewed in 30 days）

Interdisciplinary Communication Platform:

Focused on all research related to integrated diagnostics, with a broad scope for manuscript acceptance.

Publication Fee Sponsored:

Article Publication Charges (APCs) waived for early submissions.

Rapid Publication:

First peer-review decision completed within 30 days of submission.

期刊信息

官方网站和投稿系统

期刊主页：

https://www.sciencedirect.com/journal/integrated-diagnostics

投稿地址：

https://www.editorialmanager.com/intdia/default2.aspx

联系我们：

邮箱：id_journal@zju.edu.cn

编辑部地址：浙江省杭州市上城区庆春东路3号

Guide for authors

【官网信息】

About the journal

Aims and scope

This

journal focuses on translational research and clinical diagnostic

innovation in interdisciplinary fields. It covers key areas like novel

biomarkers, disease mechanisms, advanced diagnostic platforms, liquid

biopsy, and precision drug monitoring. Research on preclinical

diagnostics, diagnostic materials, bioinformatics, and AI-driven

computational diagnostics is also included. Integrated diagnostic

approaches and clinical validation studies are featured. The journal

also welcomes concise reviews and original research that bridge basic

science, technology, and clinical application, aiming to accelerate

diagnostic innovation and improve patient outcomes.

Peer review

This

journal follows a double anonymized review process. Your submission

will initially be assessed by our editors to determine suitability for

publication in this journal. If your submission is deemed suitable, it

will typically be sent to a minimum of two reviewers for an independent

expert assessment of the scientific quality. The decision as to whether

your article is accepted or rejected will be taken by our editors.

Read more about peer review.

Our editors are not involved in making decisions about papers which:

they have written themselves.

have been written by family members or colleagues.

relate to products or services in which they have an interest.

Any

such submissions will be subject to the journal's usual procedures and

peer review will be handled independently of the editor involved and

their research group. Read more about editor duties.

Authors

may submit a formal appeal request to the editorial decision, provided

it meets all the requirements and follows the procedure outlined in

Elsevier’s Appeal Policy. Only one appeal per submission will be

considered and the appeal decision will be final.

Special issues and article collections

The

peer review process for special issues and article collections follows

the same process as outlined above for regular submissions, except, a

guest editor may send the submissions out to the reviewers and may

recommend a decision to the journal editor. The journal editor oversees

the peer review process of all special issues and article collections to

ensure the high standards of publishing ethics and responsiveness are

respected and is responsible for the final decision regarding acceptance

or rejection of articles.

Open access

We refer you to our open access information page to learn about open access options for this journal.

Ethics and policies

Ethics in publishing

Authors must follow ethical guidelines stated in Elsevier's Publishing Ethics Policy.

Submission declaration

When authors submit an article to an Elsevier journal it is implied that:

the

work described has not been published previously except in the form of a

preprint, an abstract, a published lecture, academic thesis or

registered report. See our policy on multiple, redundant or concurrent

publication.

the article is not under consideration for publication elsewhere.

the

article's publication is approved by all authors and tacitly or

explicitly by the responsible authorities where the work was carried

out.

if

accepted, the article will not be published elsewhere in the same form,

in English or in any other language, including electronically, without

the written consent of the copyright-holder.

To verify compliance with our journal publishing policies, we may check your manuscript with our screening tools.

Authorship

All authors should have made substantial contributions to all of the following:

The conception and design of the study, or acquisition of data, or analysis and interpretation of data

Drafting the article or revising it critically for important intellectual content.

Final approval of the version to be submitted.

All

authors are accountable for all aspects of the work, to ensure that

questions related to the accuracy or integrity of any part of the work

are appropriately investigated and resolved.

Authors

should appoint a single corresponding author to communicate with the

journal during the editorial process. This individual submits the

manuscript and all required documentation to the journal, and serves as

the primary contact between the journal and the co-authors. Only the

corresponding author’s affiliation will be used to determine eligibility

for a publishing agreement, and possible discounts related to it.

Affiliations of other co-authors are not relevant for eligibility.

Changes to authorship

The

editors of this journal generally will not consider changes to

authorship once a manuscript has been submitted. It is important that

authors carefully consider the authorship list and order of authors and

provide a definitive author list at submission.

The policy of this journal around authorship changes:

All

authors must be listed in the manuscript and their details entered into

the submission system. Changes can only be made prior to acceptance,

and only if approved by the journal editor. This includes additions,

deletion, or rearrangement of author names.

Requests

to change authorship must be made by the corresponding author using the

Authorship Change Request form. The corresponding author must provide

the reason for the request to the journal editor with written

confirmation from all authors, including any authors being added or

removed, that they agree with the changes. Requests which do not comply

with the instructions outlined in the form will not be considered.

This

journal does not allow authorship changes after acceptance. This

includes additions, deletions, or the rearrangement of author names,

including changes to the corresponding author.

The review process may be paused while a change in authorship request is being considered.

Change

requests made by the authors without the Authorship Change Request form

or editor approval may result in the rejection of the manuscript, or

retraction if the article has already been published.

Declaration of competing interests

All

authors must disclose any financial and personal relationships with

other people or organizations that could inappropriately influence or

bias their work. Examples of potential competing interests include:

Employment

Consultancies

Stock ownership

Honoraria

Paid expert testimony

Patent applications or registrations

Grants or any other funding

Affiliation with the journal as an Editor or Advisory Board Member

The declarations tool should always be completed.

Authors with a journal affiliation to declare should enter the following text under “Other Activities” within the  declarations tool and should inform the journal and publisher prior to completing the submission process:

Given

their role as [insert journal role title], [insert your name] had no

involvement in the peer-review of this article and has no access to

information regarding its peer-review.  Full responsibility for the editorial process for this article was delegated to another journal editor.

Editorial

disclosure statements will be included as a footnote and/or in the

declaration of competing interest section of the article.

Authors with no competing interests to declare should select the option "I have nothing to declare".

The

resulting Word document containing your declaration should be uploaded

at the "attach/upload files" step in the submission process. It is

important that the Word document is saved in the .doc/.docx file format.

Author signatures are not required.

Funding sources

Authors

must disclose any funding sources who provided financial support for

the conduct of the research and/or preparation of the article. The role

of sponsors, if any, should be declared in relation to the study design,

collection, analysis and interpretation of data, writing of the report

and decision to submit the article for publication. If funding sources

had no such involvement this should be stated in your submission.

List funding sources in this standard way to facilitate compliance to funder's requirements:

Funding:

This work was supported by the National Institutes of Health [grant

numbers xxxx, yyyy]; the Bill & Melinda Gates Foundation, Seattle,

WA [grant number zzzz]; and the United States Institutes of Peace [grant

number aaaa].

It

is not necessary to include detailed descriptions on the program or

type of grants, scholarships and awards. When funding is from a block

grant or other resources available to a university, college, or other

research institution, submit the name of the institute or organization

that provided the funding.

If no funding has been provided for the research, it is recommended to include the following sentence:

This research did not receive any specific grant from funding agencies in the public, commercial, or not-for-profit sectors.

......

更多详见：

https://www.sciencedirect.com/journal/integrated-diagnostics/publish/guide-for-authors#about-the-journal-open-access